Navigation Links
Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
Date:5/4/2008

is may include upper respiratory tract infection, ear infection, fever, and runny nose. In children born with heart problems, Synagis was associated with reports of low blood oxygen levels and abnormal heart rhythms. Synagis should not be used in patients with a history of a severe prior reaction to Synagis or its components. Side effects, such as, skin reactions around the area where the shot was given (like redness, swelling, warmth, or discomfort) can also occur.

The pivotal trial for Synagis was called the IMpact trial and comprised a total of 1,502 children who were randomized (500 placebo, 1,002 Synagis) in a double-blind, placebo-controlled protocol where 1,486 children completed the study's follow-up.

In the IMpact trial, monthly prophylaxis with Synagis via intramuscular injections was associated with a 55-percent reduction in hospitalization as a result of RSV (p=<0.001). Reductions were observed in both children with bronchopulmonary dysplasia (38 percent reduction) and premature children without BPD (78 percent reduction). Approximately 50 percent of the children in the analysis had BPD.

For full prescribing information for Synagis, see the company's website at: http://www.medimmune.com/products/synagis/index.asp.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease, and neuroscience. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 The consumer ... evolving across industry sectors to better identify winning ... ways to engage with and understand consumers, as ... and make critical purchasing decisions. ... Practices, LLC, one area where organizations can observe ...
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
(Date:7/11/2014)... , July 11, 2014  Veran ... company, announced today the positive, cost-effective final ... innovative SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous ... a percutaneous approach to biopsy when a ... patients and physicians experience positive financial outcomes ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Veran Medical Publishes Lung Cancer Patient Management Study 2
...   Amcor Flexibles ... million in its Singen converting plant in ... of pharmaceutical packaging,and upgrades the classic converting ...      (Logo:  http://www.newscom.com/cgi-bin/prnh/20110630/465056  ) ...
... Va., June 29, 2011 The last ten years have ... Valley, Virginia. The former Pentagon employee, who survived the 9/11 ... debilitating neurological disorder. Medications controlled his tremor for ... Williams found it impossible to do anything with his dominant ...
Cached Medicine Technology:Amcor Invests €6.7 Million in the Extension of its Singen Converting Plant in Germany 2Video Features World's First Essential Tremor Patient Treated With Noninvasive MR-Guided Focused Ultrasound 2
(Date:7/14/2014)... Doctor Mike Hamilton from Inception Chiropractic ... company website. The Inception website is a place for ... It's also a place for potential clients to learn ... When contacted at his office, Doctor Hamilton said, "We're ... website. Our site is obviously a great place for ...
(Date:7/14/2014)... 2014 Love Digits LLC has successfully ... Digits. The App brings ancient astrology to the modern ... their compatibility using a five-star rating system. By entering ... instantaneously test their compatibility for love and marriage across ... app’s five-star rating system generates a weighted average of ...
(Date:7/14/2014)... Spine Team Texas continues to stay ... treatment and recovery. Currently all physical therapists at Spine ... for certification in The McKenzie Method. Two therapists, Craig ... program. , “We require certification of our therapists because ... outcomes for spine pain patients,” said Mark Hood, CEO ...
(Date:7/14/2014)... Townsend Security, a leading authority ... IBM i (AS/400, iSeries) Two Factor Authentication Partner ... threats evolve and make passwords ineffective for system ... their applications and implement two factor authentication (2FA). ... for ISVs on the IBM i platform to ...
(Date:7/14/2014)... Crystal Dental has recently announced that it will ... made via LAD Solutions in in order to increase awareness ... in order to draw in new patients that can now ... Dental offers a variety of services for both routine and ... include cosmetic dentistry procedures such as porcelain veneers and dental ...
Breaking Medicine News(10 mins):Health News:Doctor Mike Hamilton From Inception Chiropractic Websites Announces the Launch of Their New Website 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Crystal Dental Announces the Opening of New Office Location in Sacramento 2
... Centre and Kenya has been asked to spell out, account ... intended 134 million. The fund was provided to Kenya to ... have to provide the accounts of how the money was ... Kenya has been ridden with serious corruption problems that have ...
... The burden of HIV, malaria and Tuberculosis in most ... //The European Union, UNAIDS, WHO and the Indian Government ... the diseases. ,"These diseases mostly affect the ... aim to share our experiences and develop strategies to ...
... drug manufactured by German pharmaceutical company TeGenero by medical research ... designed to treat rheumatoid arthritis, leukaemia and multiple sclerosis was ... who fell seriously ill after taking part in a drug ... brain was on fire. Student Nav Modi, 24, said that ...
... an NGO official India’s population stabilization solely rests on ... which has the highest fertility rates. ,'India's population ... an immediate lead in checking population growth' A.R. Nanda, ... ,'If high growth states like Bihar and Uttar Pradesh, ...
... funds to the tune of ?4m or more will be ... This spending should take care of containing// the unhealthy trend, ... gone up by almost 50%. ,A senior medical ... problems with suicidal tendencies, according to Mr Woodward. To enable ...
... high risk of the potentially-fatal condition of pre-eclampsia, should ... Vitamin C and E. // Recent research has suggested that ... and can trigger pre-eclampsia. ,Pre-eclampsia, is a dangerous condition ... women which is a common cause of deaths and still ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: